SPIOLTO® RESPIMAT® is a fixed dose combination inhalation solution containing the long-acting muscarinic receptor antagonist (LAMA), tiotropium and the long-acting beta2-agonist (LABA), olodaterol which is delivered via the SPIOLTO® RESPIMAT® soft mist inhaler device.1

The two active ingredients provide additive bronchodilation due to their different modes of action.1 Since muscarinic receptors appear to be more prominent in the central airways while beta2-adrenoceptors have a higher expression level in the peripheral airways, a combination of tiotropium and olodaterol should provide optimal bronchodilatation in all regions of the lungs.1

Tiotropium - Tiotropium bromide is a long-acting, specific antagonist at muscarinic receptors.1

Olodaterol - Olodaterol has a high affinity and high selectivity to the human beta2-adrenoceptor.1

Reference

  1. SPIOLTO® RESPIMAT® Summary of Product Characteristics.

Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.